Pascal Bamford - 01 Mar 2025 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Signature
/s/ Pascal Bamford by Brian McKelligon, Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
01 Mar 2025
Net transactions value
-$6,276
Form type
4
Filing time
04 Mar 2025, 17:09:48 UTC
Previous filing
21 Nov 2024
Next filing
02 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Tax liability $2,091 -1,283 -0.61% $1.63 208,975 01 Mar 2025 Direct F1
transaction AKYA Common Stock Tax liability $4,184 -2,567 -1.2% $1.63 206,408 01 Mar 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to cover taxes on a restricted stock unit award previously granted on February 23, 2023, which vests in four (4) annual equal installments beginning on March 1, 2024 and annually thereafter until fully vested.
F2 Represents shares withheld to cover taxes on a restricted stock unit award previously granted on February 22, 2024, which vests in four (4) annual equal installments beginning on March 1, 2025 and annually thereafter until fully vested.